endo_fellow_rk
TL3 Endocrinology fellow · Chicago, IL, US
Endocrinology fellow. I mostly answer bloodwork-interpretation questions and try to talk people out of over-reading a single result.
Joined 31 August 2024 · last posted 10h · groups: clinicians
149 posts, newest first. Showing up to 150.
-
Second pass at: Sleep apnoea improving and the equipment implications Replied, post #97 · Wellbeing › Sleep · 27 Jul 2026 · 4 likes The published data on sleep outcomes in this class is thinner than the volume of discussion, which is worth saying plainly. I would rather post the uncertainty than…
-
How shortages have affected compounding permissions Replied, post #68 · Access › Shortages · 25 Jul 2026 · 0 likes Confirming post #65 from a second method, which matters more than confirming it from a second person. Trying to state the shortages position in a way that someone who…
-
A structured critique template this community uses — a second dataset Replied, post #47 · Evidence › Study critique · 23 Jul 2026 · 23 likes Generalisability and validity are separate axes. A trial can be internally impeccable and still tell you nothing about the person asking. Genuinely open to being wrong…
-
What a certificate commits its issuer to Replied, post #53 · Analytics › COA interpretation · 18 Jul 2026 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
Why I now write the concentration on the vial in marker Replied, post #5 · Practice › Reconstitution · 13 Jul 2026 · 0 likes Narrowing post #3, because the general version has more than one answer. The best check on any reconstitution calculation is to do it twice by two different routes —…
-
Secretagogues and glucose tolerance: the mechanistic concern Replied, post #58 · Compounds › Secretagogues & GH axis · 2 Jul 2026 · 0 likes I changed my mind about secretagogues and glucose tolerance after someone here asked me for the source and I could not produce one. That is worth saying out loud…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #36 · Practice › Administration · 1 Jul 2026 · 14 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #57 · Practice › Dosing & titration · 1 Jul 2026 · 26 likes Everything in post #53 holds. The case it does not cover is the one I have. Micro-titration has a well-known answer and a correct answer, and the interesting work is…
-
Publication patterns in the BPC-157 literature, examined Replied, post #24 · Compounds › Repair & healing peptides · 29 Jun 2026 · 0 likes I have three months of notes on publication patterns and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #36 · Access › Pricing · 22 Jun 2026 · 28 likes The version of manufacturer assistance programmes that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #33 · Analytics › Method validation · 22 Jun 2026 · 6 likes Reporting a result to more decimal places than the method's precision supports is a small dishonesty that appears everywhere. A method with a two per cent relative…
-
Purity assay versus content assay: two different numbers Replied, post #7 · Analytics › COA interpretation · 18 Jun 2026 · 4 likes Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The difference between a TFA salt and an acetate salt can be…
-
Insurance and replacement policies, compared Replied, post #20 · Sourcing › Logistics · 14 Jun 2026 · 3 likes The arithmetic in post #19 is right; the assumption feeding it is the part to check. Insurance and replacement policies is worth one more sentence than it usually gets,…
-
Racemisation and why it is invisible to a mass measurement Replied, post #24 · Analytics › Impurities & related substances · 9 Jun 2026 · 1 like Everything in post #20 holds. The case it does not cover is the one I have. On racemisation: the maintained page in the documentation commons covers the general case…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #29 · Start Here › How to Ask · 9 Jun 2026 · 10 likes Post #26 answers the question as asked. The question underneath it is different. A photograph of a vial is rarely useful and a photograph of a document usually is.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #56 · Access › Insurance & coverage · 5 Jun 2026 · 21 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Revisiting: Theoretical plates: useful number or ritual? Replied, post #11 · Analytics › HPLC & UHPLC · 4 Jun 2026 · 3 likes I read post #7 twice before replying, because I had assumed the opposite. Counterpoint on Theoretical plates, offered without confidence: the same observation is…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #38 · Practice › Storage & stability · 4 Jun 2026 · 0 likes Narrowing post #35, because the general version has more than one answer. Temperature excursions in transit are common and are not all equal. A few hours warm is a…
-
How to disagree with an answer you were given, well Replied, post #5 · Start Here › How to Ask · 2 Jun 2026 · 5 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #52 · Evidence › Journal club · 2 Jun 2026 · 0 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
An 18-month record including the parts that went badly Replied, post #27 · Outcomes › Progress reports · 29 May 2026 · 0 likes I read the earlier replies on 18-month record twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was said…
-
Spreadsheets: an appreciation — what changed since Replied, post #52 · Lounge › Off topic · 25 May 2026 · 0 likes I would be cautious about generalising from the Spreadsheets example above. It is a good example. It is one example.
-
Private prescribing in the UK: what is actually involved Replied, post #21 · Regional › UK & Ireland · 23 May 2026 · 0 likes Taking post #18 at face value and following it one step further. Distinguishing three things in the private prescribing discussion that keep getting used…
-
Micro-titration: a disputed topic, argued properly Replied, post #78 · Practice › Dosing & titration · 22 May 2026 · 5 likes The most useful thing anyone has posted about micro-titration in this category was a table of what had been measured and by whom. That is what I would want again.
-
Alcohol: what is documented and what is folklore Replied, post #17 · Practice › Interactions · 18 May 2026 · 0 likes This is the answer, and the reason it is the answer is the more useful part.
-
Injection volume, overload, and peak distortion Replied, post #10 · Analytics › HPLC & UHPLC · 17 May 2026 · 0 likes A relative retention time against a known peak travels much better than an absolute one, and almost nobody reports it. The part I am sure of is shorter than the part I…
-
Tracking intake honestly when appetite is absent Replied, post #22 · Nutrition & Training › Protein & intake · 11 May 2026 · 10 likes On post #19 — agreed on the reasoning, with one qualification. Where somebody reports losing strength, intake and training stimulus are the first two things to look at…
-
Revisiting: Primary endpoint hierarchies and why order matters Replied, post #11 · Evidence › Trials · 8 May 2026 · 0 likes Primary endpoint hierarchies came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
-
Request: show the solution author in the topic list — what changed since Replied, post #71 · Meta › Feature requests · 3 May 2026 · 3 likes The arithmetic in post #70 is right; the assumption feeding it is the part to check. Effort estimation: some features are trivial to implement; others are substantial…
-
Constipation management, with a dietitian's contribution Replied, post #60 · Practice › Side effects · 2 May 2026 · 24 likes Thank you for taking the time. That was more work than a reply usually is.
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #45 · Evidence › Journal club · 1 May 2026 · 0 likes Post #43 put the caveat in the right place and I want to underline it. Reading this indirect comparison thread as someone who came in with a fixed view: the third and…
-
Blind submission and why it changes minds — the long version Replied, post #47 · Sourcing › Independent verification · 29 Apr 2026 · 28 likes Taking Blind submission seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled comparison, and…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #58 · Sourcing › Vendor reports · 28 Apr 2026 · 25 likes Building on post #57 rather than restating it. Report the certificate figure alongside the independent one. The comparison is the point and it is the part most often…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #21 · Devices › Syringes & needles · 22 Apr 2026 · 4 likes On 0.3 ml versus 0.5 ml, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #13 · Analytics › Home & field testing · 19 Apr 2026 · 7 likes Picking up post #12: that is the part I would want checked first. Documenting home checks with dates and lots makes them accumulate into something. Undocumented ones…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #14 · Practice › Reconstitution · 13 Apr 2026 · 0 likes A vial that will not fully dissolve: check in order: is the diluent genuinely room temperature (some preservatives crystallise in cold), is the vial being warmed gently…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #49 · Data & Tools › Datasets · 10 Apr 2026 · 2 likes Sensible. I would want the same detail before I acted on it either.
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #80 · Practice › Interactions · 6 Apr 2026 · 0 likes The documentation on Metformin co-administration is better than this thread and I say that as someone who has posted in the thread.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #98 · Clinical › Special populations · 5 Apr 2026 · 32 likes Post #97 is right about the mechanism and I think understates the practical bit. Pregnancy and pregnancy planning: I would want to see the raw numbers rather than the…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #30 · Clinical › Bloodwork · 3 Apr 2026 · 28 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
-
Coming back to: Training through a dose escalation week Replied, post #58 · Nutrition & Training › Resistance training · 22 Mar 2026 · 3 likes The documentation on Training through a dose escalation is better than this thread and I say that as someone who has posted in the thread.
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #80 · Lounge › Introductions · 16 Mar 2026 · 28 likes There is: the practice category, and the calculators, both written for exactly that. Nothing there assumes chemistry, and the maintained documents show their working so…
-
Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #63 · Compounds › Cagrilintide & amylin analogues · 13 Mar 2026 · 5 likes Worth separating two things that post #61 runs together. Having read the whole nausea profile of amylin analogues thread before replying: the question in the first post…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #26 · Compounds › Repair & healing peptides · 10 Mar 2026 · 0 likes Picking up post #23: that is the part I would want checked first. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade a…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #46 · Data & Tools › Calculators · 6 Mar 2026 · 32 likes Post #44 put the caveat in the right place and I want to underline it. A note on how titration planner refuses gets discussed rather than on titration planner refuses…
-
Measurement error in a self-reported exposure Replied, post #53 · Evidence › Study critique · 24 Feb 2026 · 11 likes Post #51 put the caveat in the right place and I want to underline it. I would call the community position on measurement error likely rather than established, and I…
-
Why this subcategory is stricter about sourcing than most Replied, post #3 · Compounds › Secretagogues & GH axis · 24 Feb 2026 · 23 likes A mass result for a short peptide is more discriminating than for a long one, because a single residue difference is a larger proportion of the total. That makes…
-
Second pass at: Identical chromatograms across two different lots Replied, post #24 · Sourcing › Red flags · 24 Feb 2026 · 1 like Helpful, and short, which on this subject is harder than long.
-
Air bubbles in a subcutaneous injection: the honest risk assessment — does this still… Started this topic · Practice › Administration · 19 Feb 2026 · 19 likes Asking directly, because I could not find a straight answer: Air bubbles in a subcutaneous injection: the honest risk assessment — does this still hold? An honest…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #9 · Analytics › HPLC & UHPLC · 16 Feb 2026 · 26 likes On integration: where the baseline is drawn matters more than most people realise. On a clean chromatogram with well-resolved peaks the choice is inconsequential. On a…
-
Designing a personal experiment that could change your mind — one year on Replied, post #10 · Research Methods › N-of-1 designs · 11 Feb 2026 · 0 likes The most useful reply I ever got about Designing a personal experiment was a request to state my units. It sounds like pedantry and it has saved me twice.
-
Revisiting: Journal club: SURMOUNT-1, read without the press release Replied, post #16 · Evidence › Journal club · 10 Feb 2026 · 3 likes The version of SURMOUNT-1 that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #120 · Analytics › COA interpretation · 28 Jan 2026 · 12 likes The distinction between release testing and characterisation is one industrial documents make and retail ones usually do not. It is the difference between "we tested…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #25 · Practice › Storage & stability · 24 Jan 2026 · 9 likes Refrigeration slows degradation. Repeated warming and cooling is worse than continuous refrigeration. Light exposure is worth avoiding. The concentration matters…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #48 · Clinical › Special populations · 23 Jan 2026 · 5 likes Taking post #47 at face value and following it one step further. What I would check first on Pregnancy and pregnancy planning is whether the thing being measured moved…
-
Citation sweep results: how many references did not say what was claimed Replied, post #34 · Meta › Wiki maintenance · 21 Jan 2026 · 1 like Filing a mild objection to the consensus on citation sweep results. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit.
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #35 · Evidence › Trials · 14 Jan 2026 · 7 likes My understanding of non-inferiority margins is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #89 · Practice › Side effects · 13 Jan 2026 · 0 likes Saving this. It is the version I will quote when the question comes round again.
-
Filter needles: when they help and what they cost you Replied, post #17 · Devices › Syringes & needles · 2 Jan 2026 · 8 likes Marking my uncertainty on filter needles explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #29 · Practice › Side effects · 27 Dec 2025 · 23 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #7 · Access › International · 10 Dec 2025 · 4 likes Temperature-controlled material and long-haul travel is a practical problem with practical solutions, none of which are on the packaging. That is the version I use. It…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #61 · Clinical › Special populations · 3 Dec 2025 · 0 likes Post #59 describes the usual case. This is about the unusual one. Body weight at the extremes of the studied range affects exposure and the trials rarely reported…
-
Robustness: the parameters worth deliberately varying Started this topic · Analytics › Method validation · 13 Nov 2025 · 0 likes Robustness: the parameters worth deliberately varying Writing it up because I had to work it out twice and would rather nobody else did. A narrow question about…
-
Reading an interaction checker output critically Replied, post #40 · Practice › Interactions · 10 Nov 2025 · 31 likes Absence of an interaction study is not evidence of no interaction. A great many combinations discussed here have simply never been studied, and saying so is more useful…
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #18 · Practice › Side effects · 5 Nov 2025 · 20 likes I have been on both sides of the Constipation management argument in this category within eighteen months, which should tell you how strong the evidence for either side…
-
Payment mechanics and the recovery options that do not exist Replied, post #21 · Sourcing › Payments · 19 Oct 2025 · 1 like Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Second pass at: Programming during a large energy deficit Replied, post #45 · Nutrition & Training › Resistance training · 19 Oct 2025 · 23 likes Picking up post #42: that is the part I would want checked first. Adaptation and plateau: if strength does not change for weeks, that is stability, not backsliding.…
-
Sleep tracking data and its considerable limitations Replied, post #14 · Wellbeing › Sleep · 16 Oct 2025 · 0 likes This settles it for me, at least until somebody posts a reason it should not.
-
Dead volume across syringe and needle combinations Replied, post #11 · Devices › Syringes & needles · 14 Oct 2025 · 0 likes Worth separating two things that post #7 runs together. On dead volume across syringe: the maintained page in the documentation commons covers the general case with…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #101 · Practice › Administration · 9 Oct 2025 · 23 likes Post #100 is the version of this I will quote in future. One addition. Pinch is a question about a distribution, not about a value, and treating it as a value is what…
-
Compounds this community declines to help with, and why Replied, post #45 · Compounds › Other compounds · 2 Oct 2025 · 2 likes I had written a reply contradicting post #41 and deleted it. Here is what survived. Thymosin alpha-1 has a regulatory history in several jurisdictions and a real…
-
Temperature loggers worth the money Replied, post #35 · Devices › Cold chain · 28 Sep 2025 · 0 likes Temperature loggers in the parcel exist and are occasionally used for high-value shipments. They are the only thing that turns an argument about transit into a record.…
-
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #10 · Analytics › HPLC & UHPLC · 24 Sep 2025 · 0 likes Whatever the answer on integrator turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the correction.
-
The nausea timeline across the first four weeks, with a tabulated log Replied, post #89 · Practice › Side effects · 24 Sep 2025 · 5 likes Post #85 describes the usual case. This is about the unusual one. Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre…
-
A preprint whose numbers changed substantially at publication Replied, post #61 · Evidence › Preprints · 21 Sep 2025 · 9 likes Answering the question post #59 raises rather than the one it answers. Reading a preprint properly means doing some of the reviewer's job: methods first, then whether…
-
Pooling trials with different estimands — what changed since Replied, post #25 · Evidence › Meta-analyses · 16 Sep 2025 · 6 likes Coming back to post #23, because the follow-up matters more than the original answer. Study quality and weighting: some meta-analyses weight all studies equally; others…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #88 · Evidence › Study critique · 15 Sep 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #63 · Evidence › Study critique · 14 Sep 2025 · 5 likes Surrogate endpoints are not automatically bad and their validity is compound-specific and population-specific. The question is whether this surrogate has been validated…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #6 · Data & Tools › Datasets · 6 Sep 2025 · 1 like Temporal bias: older data in a dataset might reflect conditions (supplier, formulation, context) that have changed. Newer data is more current.
-
Column chemistry choices for a 40-residue peptide Replied, post #27 · Analytics › HPLC & UHPLC · 3 Sep 2025 · 17 likes Column chemistry choices: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would…
-
Second pass at: Isotonicity and what happens when you get it wrong Replied, post #6 · Pharmacology › Formulation chemistry · 28 Aug 2025 · 0 likes Isotonicity has been discussed here with more heat than it deserves, mostly because two definitions have been in play the whole time.
-
A friction point in the promotion workflow Replied, post #8 · Meta › Site feedback · 28 Aug 2025 · 0 likes Friction point has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #5 · Practice › Storage & stability · 17 Aug 2025 · 14 likes The opening post describes the usual case. This is about the unusual one. Clarity is a weak test. A solution can lose a significant fraction of its active content to…
-
[2026 update] Cold solution and stinging: the simplest fix Replied, post #8 · Practice › Administration · 11 Aug 2025 · 0 likes Adding the measurement that post #7 says would settle it. Since Cold solution and stinging keeps coming up, it should probably be a maintained page rather than a…
-
How to research a compound with no human data without deceiving yourself Replied, post #101 · Compounds › Other compounds · 4 Aug 2025 · 6 likes Research a compound was covered in the wiki last year and the page has a review date on it, which is a better starting point than my memory of a thread.
-
Research-use-only labelling: what it means and what it does not Replied, post #18 · Sourcing › Regulatory · 3 Aug 2025 · 21 likes Nothing in this subcategory is legal advice, and the members who work in regulated environments are the most careful to say so. A qualification I should have led with…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #98 · Compounds › Tirzepatide · 1 Aug 2025 · 14 likes Worth separating two things that post #94 runs together. Where I have landed on GIP component of tirzepatide, having got it wrong once in public: the direction is…
-
Travel coolers and how long they really hold Replied, post #7 · Devices › Cold chain · 30 Jul 2025 · 0 likes The practical question after a warm arrival is what to do, and there is no test at home that answers it. Independent testing is the only route to an actual answer.
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #31 · Start Here › How to Ask · 29 Jul 2025 · 32 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context.
-
Freeze-thaw and why one cycle is not the same as five — a second dataset Replied, post #11 · Practice › Storage & stability · 22 Jul 2025 · 0 likes Confirming post #8 from a second method, which matters more than confirming it from a second person. Clarity is a weak test. A solution can lose a significant fraction…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 18 Jul 2025 · 8 likes Post #8 describes the usual case. This is about the unusual one. On analysis: an amylin analogue and its aggregates are not equally detectable by a standard…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Started this topic · Clinical › Special populations · 16 Jul 2025 · 18 likes Asking directly, because I could not find a straight answer: Older adults, sarcopenia risk, and the trade-off nobody quantifies — does this still hold? Older adults:…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #57 · Evidence › Trials · 16 Jul 2025 · 3 likes Two sentences on Sample size calculations and then I will stop, because the rest is speculation and the thread is better without mine. What is documented is narrow.…
-
High-resolution MS on aggregates and what it can see Replied, post #19 · Analytics › Mass spectrometry · 8 Jul 2025 · 2 likes Post #17 and I disagree about the size of the effect, not about the direction. Where I have landed on high-resolution, having got it wrong once in public: the direction…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #57 · Compounds › Repair & healing peptides · 3 Jul 2025 · 0 likes Reading this TB-500 and thymosin beta-4 thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Journal club: SURMOUNT-1, read without the press release Replied, post #148 · Evidence › Journal club · 30 Jun 2025 · 31 likes Everything in post #146 holds. The case it does not cover is the one I have. Assigning the statistics to somebody who will read the analysis plan rather than the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #112 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 1 like Confirming post #109 from a second method, which matters more than confirming it from a second person. Something worth flagging about CagriSema phase 2 paper: the…
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #22 · Nutrition & Training › Protein & intake · 5 Jun 2025 · 2 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound.
-
Individual participant data versus aggregate data Replied, post #34 · Evidence › Meta-analyses · 4 Jun 2025 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
-
Revisiting: Why a compound being unapproved is not the same as being illegal to possess Replied, post #17 · Sourcing › Regulatory · 3 Jun 2025 · 4 likes This settles it for me, at least until somebody posts a reason it should not.
-
Why fasting instructions for oral semaglutide are not optional advice — does this still… Replied, post #27 · Compounds › Oral incretins · 5 May 2025 · 1 like Narrowing post #25, because the general version has more than one answer. Anyone comparing published oral and injectable efficacy should check whether the comparison is…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #11 · Analytics › Home & field testing · 30 Apr 2025 · 0 likes Molecular tests: DNA or RNA tests are not applicable to peptides, which do not contain nucleic acids. Peptide-specific tests rely on protein recognition, not…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #21 · Sourcing › Independent verification · 17 Apr 2025 · 0 likes Worth separating two things that post #19 runs together. Combining a chromatographic result with a documentation review gives a more complete picture than two…
-
Reading a chromatogram someone posted without axes Replied, post #21 · Analytics › HPLC & UHPLC · 14 Apr 2025 · 4 likes Peaks that do not elute do not appear in the area percentage. Aggregates and strongly retained species can be entirely invisible to a standard method, which is a…
-
Adducts: sodium, potassium, and the peak you did not expect Replied, post #63 · Analytics › Mass spectrometry · 11 Apr 2025 · 0 likes Response in electrospray is not proportional to abundance across different species. Using peak intensities from a mass spectrum to estimate proportions is a mistake…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #54 · Clinical › Comorbidities · 9 Apr 2025 · 2 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. Adding the caveat now so it does not…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #49 · Compounds › Cagrilintide & amylin analogues · 28 Mar 2025 · 0 likes Adding a null result on cagrilintide alone. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
-
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #26 · Sourcing › Vendor reports · 26 Mar 2025 · 14 likes Reports of ordinary results are more valuable than reports of remarkable ones, precisely because only the remarkable ones get posted elsewhere.
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #37 · Compounds › Oral incretins · 18 Mar 2025 · 0 likes Oral semaglutide's bioavailability is low and variable, which is why the dose numbers are an order of magnitude different from the injectable. That is a formulation…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #117 · Pharmacology › Receptor biology · 17 Mar 2025 · 4 likes This follows post #116 rather than contradicting it. Adding what did not work for me on biased agonism, since the failures never get written up and they are half the…
-
Certificates issued by the seller versus by a laboratory Replied, post #4 · Analytics › COA interpretation · 12 Mar 2025 · 8 likes I had written a reply contradicting post #2 and deleted it. Here is what survived. An itemised related-substances table with retention times says considerably more…
-
Maintainer handover: how it works Replied, post #3 · Meta › Wiki maintenance · 12 Mar 2025 · 0 likes Careful with that. A short duplicated paragraph is sometimes better than a link, because the reader who needs it is mid-task and will not follow a link. The test is…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #120 · Data & Tools › Calculators · 8 Mar 2025 · 6 likes Rounding behaviour is where two tools disagree. One rounding to the nearest graduation and one to two decimal places will produce different advice from identical…
-
Follow-up: Requesting a page: what makes a good request Replied, post #8 · Documentation › Wiki requests · 8 Mar 2025 · 12 likes Where I part company with post #4, and it is a narrow parting. Objections to a request belong in the open, and a request that survives an objection is a stronger page…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #126 · Sourcing › Regulatory · 5 Mar 2025 · 0 likes The claim about pharmaceutical compounding rules upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post…
-
Consistent declarations and why they matter more than clever ones Replied, post #123 · Sourcing › Logistics · 4 Mar 2025 · 0 likes Post #120 answers the question as asked. The question underneath it is different. The claim about consistent declarations upthread is stronger than its source supports.…
-
Canadian access and provincial variation Replied, post #32 · Regional › North America · 29 Jan 2025 · 29 likes Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does.
-
A supplier that answers analytical questions with restated claims Replied, post #15 · Sourcing › Red flags · 26 Jan 2025 · 0 likes Where I part company with post #11, and it is a narrow parting. Reporting rather than recommending, on supplier. What happened is above. Whether it should have is a…
-
[2026 update] Lipid changes during rapid weight loss: the expected trajectory Replied, post #27 · Clinical › Bloodwork · 22 Jan 2025 · 19 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #3 · Compounds › Cagrilintide & amylin analogues · 18 Jan 2025 · 7 likes The CagriSema phase 2 paper: a fixed combination of the two components in one weekly injection. The trade-off of a fixed combination is that you cannot titrate the…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #85 · Compounds › Semaglutide · 16 Jan 2025 · 11 likes Taking post #84 at face value and following it one step further. The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares…
-
Journal club: SUSTAIN 6 and its retinopathy signal — does this still hold? Replied, post #21 · Evidence › Journal club · 2 Jan 2025 · 0 likes That is a cleaner way of putting what I was circling around.
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #20 · Evidence › Journal club · 31 Dec 2024 · 0 likes Everything in post #16 holds. The case it does not cover is the one I have. The question underneath STEP 4 is usually "how would I tell?" rather than "what is true?",…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #103 · Compounds › Semaglutide · 25 Dec 2024 · 15 likes On post #101 — agreed on the reasoning, with one qualification. Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate,…
-
Building a sensible monitoring schedule with your prescriber Replied, post #83 · Clinical › Bloodwork · 22 Dec 2024 · 8 likes Time of day: some biomarkers vary across the day. Cortisol in the morning differs from cortisol in the evening. Comparing results from different times of day is…
-
Fixed versus detachable needles: the trade-offs Replied, post #35 · Devices › Syringes & needles · 6 Dec 2024 · 4 likes An observation about fixed versus detachable needles that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #72 · Compounds › Tirzepatide · 5 Dec 2024 · 0 likes On post #68 — agreed on the reasoning, with one qualification. Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards.…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #21 · Compounds › Other compounds · 16 Nov 2024 · 17 likes Research-use-only status is a legal classification, not a safety classification. It means the compound is sold for laboratory use and not for human consumption or…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #48 · Compounds › Repair & healing peptides · 13 Nov 2024 · 7 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #102 · Compounds › Other compounds · 8 Nov 2024 · 15 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Time to steady state after a dose increase Replied, post #110 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 0 likes Picking up post #107: that is the part I would want checked first. A missed weekly dose perturbs a slowly moving average rather than creating a trough. That is the…
-
SURPASS-2 and the comparator dose question that will not go away Replied, post #47 · Compounds › Tirzepatide · 2 Nov 2024 · 10 likes SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a pharmacological intervention at that time of publication. It also reported a clear dose…
-
Transporting a vial for a weekend away Replied, post #6 · Practice › Storage & stability · 24 Oct 2024 · 6 likes Transporting a vial is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #47 · Wellbeing › Mental health · 23 Oct 2024 · 0 likes Everything in post #45 holds. The case it does not cover is the one I have. Maintenance brings a different set of psychological questions from loss, and the discussion…
-
Requesting a page: what makes a good request — what changed since Replied, post #68 · Documentation › Wiki requests · 11 Oct 2024 · 28 likes Link the topics that prompted the request. The discussion is the evidence that the question recurs.
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #28 · Access › Shortages · 9 Oct 2024 · 0 likes Pharmacy-level availability varies enormously during a shortage, so two honest accounts from the same city can be opposite. I would rather say I do not know than round…
-
Second pass at: Hoarding and why it makes a shortage worse Replied, post #11 · Access › Shortages · 9 Oct 2024 · 7 likes The published shortage register maintained by the national regulator is the authoritative source here, and it is updated far more often than any thread.
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #30 · Compounds › Other compounds · 3 Oct 2024 · 8 likes Solubility varies far more across this subcategory than within the incretins. A compound that needs a specific diluent or a specific pH is not being difficult; it has a…
-
Why our vendor pages link the storefront and mark it sponsored Replied, post #8 · marked as the solution · Sourcing › Vendor reports · 22 Sep 2024 · 10 likes Adding the boring version of vendor pages link the storefront, because the interesting version keeps getting posted and the boring one is usually right. Check the…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #26 · Clinical › Bloodwork · 13 Sep 2024 · 28 likes Narrowing post #24, because the general version has more than one answer. I would call the community position on bring a laboratory likely rather than established, and…
-
[2026 update] People with a low starting BMI: where the evidence stops Replied, post #20 · Clinical › Special populations · 6 Sep 2024 · 0 likes Coming back to post #16, because the follow-up matters more than the original answer. Post-surgical populations, particularly after procedures affecting the…
-
Correlation in a self-tracked dataset: what it can support Replied, post #83 · Research Methods › Statistics · 23 Aug 2024 · 26 likes Before the thread moves on from correlation — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of four…
-
Correlation in a self-tracked dataset: what it can support Replied, post #68 · Research Methods › Statistics · 23 Aug 2024 · 16 likes Rounding and significant figures carry information about precision. A figure quoted to four significant figures from a method with two per cent variability is…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #10 · Sourcing › Independent verification · 21 Aug 2024 · 0 likes Cross-checking one lot with two services independently is the cleanest test available and is rarely done because it costs twice as much.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #24 · Analytics › COA interpretation · 9 Aug 2024 · 2 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #82 · Evidence › Journal club · 30 Jul 2024 · 0 likes Post #78 and I disagree about the size of the effect, not about the direction. The confident answers on LEADER and the well-sourced answers are not the same answers,…
-
Blind submission and why it changes minds Replied, post #19 · Sourcing › Independent verification · 21 Jul 2024 · 21 likes Blind sampling: submitting without the laboratory or seller knowing the source removes the two easiest ways for a result to be shaped: selective submission and…
-
How this community labels and discusses unrefereed work Replied, post #87 · Evidence › Preprints · 15 Jul 2024 · 20 likes Post #84 is the version of this I will quote in future. One addition. The claim about community labels upthread is stronger than its source supports. I have read the…
-
Assessing a warm arrival: the decision process — one year on Replied, post #69 · Sourcing › Logistics · 31 May 2024 · 0 likes Anyone deciding whether a delay is a problem should ask what would change if they waited another week. Usually the answer is nothing. The literature is thinner on this…